Showing results (941-950 of 1,041) with videos related to
Sort By:
Pageof 105
International Journal of Molecular Sciences|August 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous HistologyLinda E Kelemen, Madalene Earp, Brooke L Fridley, et al.American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.Nature Communications|August 11, 2018
Identification of nine new susceptibility loci for endometrial cancerTracy A O'Mara, Dylan M Glubb, Frederic Amant, et al.Molecular Nutrition & Food Research|July 29, 2014
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma riskLinda E Kelemen, Kathryn L Terry, Marc T Goodman, et al.Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association ConsortiumHelen Warren, Frank Dudbridge, Olivia Fletcher, et al.International Journal of Cancer|April 19, 2016
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancerJiajun Shi, Yanfeng Zhang, Wei Zheng, et al.Gynecologic Oncology|December 22, 2014
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyAlice W Lee, Jonathan P Tyrer, Jennifer A Doherty, et al.Cancer Research|November 26, 2013
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Bridget Charbonneau, Matthew S Block, William R Bamlet, et al.Cancer Research|March 12, 2017
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.Pageof 105